Your browser doesn't support javascript.
loading
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.
Tap, William D; Jones, Robin L; Van Tine, Brian A; Chmielowski, Bartosz; Elias, Anthony D; Adkins, Douglas; Agulnik, Mark; Cooney, Matthew M; Livingston, Michael B; Pennock, Gregory; Hameed, Meera R; Shah, Gaurav D; Qin, Amy; Shahir, Ashwin; Cronier, Damien M; Ilaria, Robert; Conti, Ilaria; Cosaert, Jan; Schwartz, Gary K.
Afiliação
  • Tap WD; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. Electronic address: tapw@mskcc.org.
  • Jones RL; University Washington, Seattle, WA, USA; The Royal Marsden Hospital, London, UK.
  • Van Tine BA; Washington University in St Louis, St Louis, MO, USA.
  • Chmielowski B; UCLA Medical Center, Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Elias AD; University of Colorado Cancer Center, Aurora, CO, USA.
  • Adkins D; Washington University in St Louis, St Louis, MO, USA.
  • Agulnik M; Northwestern University, Chicago, IL, USA.
  • Cooney MM; University Hospitals Case Medical Center, Seidman Cancer Center, Division of Hematology and Oncology, Cleveland, OH, USA.
  • Livingston MB; Carolinas Healthcare System, The Charlotte-Mecklenburg Hospital Authority, Charlotte, NC, USA.
  • Pennock G; Baptist MD Anderson Cancer Center, Jacksonville, FL, USA.
  • Hameed MR; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Shah GD; Novartis Pharmaceuticals, East Hanover, NJ, USA.
  • Qin A; Eli Lilly and Company, Bridgewater, NJ, USA.
  • Shahir A; Eli Lilly and Company, Windlesham, Surrey, UK.
  • Cronier DM; Eli Lilly and Company, Windlesham, Surrey, UK.
  • Ilaria R; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
  • Conti I; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
  • Cosaert J; Eli Lilly and Company, Bridgewater, NJ, USA.
  • Schwartz GK; Columbia University School of Medicine, New York, NY, USA.
Lancet ; 388(10043): 488-97, 2016 Jul 30.
Article em En | MEDLINE | ID: mdl-27291997
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Protocolos de Quimioterapia Combinada Antineoplásica / Doxorrubicina / Antibióticos Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Protocolos de Quimioterapia Combinada Antineoplásica / Doxorrubicina / Antibióticos Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2016 Tipo de documento: Article